Add-On Ramelteon in Bipolar I Disorder With Clinically Significant Sleep Disturbance
Status:
Terminated
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to evaluate the safety and efficacy of ramelteon
(Rozerem™) as an add-on treatment for sleep problems in patients with bipolar disorder. This
study will determine whether or not the addition of ramelteon to ongoing medication(s) for
bipolar disorder is useful in improving sleep.